MAPK activated kinase 2 inhibition shifts the chemokine signature in arthritis synovial fluid mononuclear cells from CXCR3 to CXCR2

Tue Wenzel Kragstrup(Aarhus University), Bent Deleuran(Aarhus University), Søren Lomholt(Aarhus University), Morten Aagaard Nielsen(Aarhus University Hospital), Peter Schäfer(Bristol-Myers Squibb (United States)), Anne Sofie Sørensen(Aarhus University), Mads Brüner(Aarhus University)
International Immunopharmacology
September 27, 2022
Cited by 2


Related Papers